Is NBIO or RYLD a better dividend investment in 2026?

NBIO currently yields 666666.67% with a 5% 5-year dividend growth rate. RYLD yields 4.00% with 5% growth. The better choice depends on your goal: NBIO offers higher current income.

What is the dividend yield difference between NBIO and RYLD?

NBIO has a forward dividend yield of 666666.67% ($2.00/share annually). RYLD yields 4.00% ($2.00/share annually). The yield gap is 666662.67 percentage points.

Home › Compare › NBIO vs RYLD

NBIO vs RYLD: Dividend Comparison 2026

NBIO yields 666666.67% · RYLD yields 4.00%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NBIO wins by $8.275235618773884e+34M in total portfolio value

INVESTMENT

TIME HORIZON10 years

NBIO

● Live price

666666.67%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$8.275235618773884e+34M

Annual income

$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00

Full NBIO calculator →

RYLD

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$28.0K

Annual income

$899.19

Full RYLD calculator →

Portfolio growth — NBIO vs RYLD

📍 NBIO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NBIO	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NBIO + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NBIO pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NBIO

Annual income on $10K today (after 15% tax)

$56,666,666.67/yr

After 10yr DRIP, annual income (after tax)

$70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/yr

RYLD

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$764.31/yr

At 15% tax rate, NBIO beats the other by $70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NBIO + RYLD for your $10,000?

NBIO: 50%RYLD: 50%

100% RYLD50/50100% NBIO

Portfolio after 10yr

$4.137617809386942e+34M

Annual income

$41,363,972,714,609,160,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.97%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NBIO buys

RYLD buys

No recent congressional trades found for NBIO or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNBIORYLD

Forward yield	666666.67% ✓	4.00%
Annual dividend / share	$2.00	$2.00
Payout ratio	50%	50%
1-year div growth	0%	5% ✓
5-year div CAGR	0%	5% ✓
Portfolio after 10y	$8.275235618773884e+34M	$28.0K ✓
Annual income after 10y	$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00 ✓	$899.19
Total dividends collected	$8.275075881065991e+34M ✓	$6.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: NBIO vs RYLD ($10,000, DRIP)

Year	NBIO Portfolio	NBIO Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$66,677,367	$66,666,666.67	$11,120	$420.00	+$66.67M → NBIO
2	$415,506,651,117	$415,435,306,334.37	$12,357	$458.31	+$415506.64M → NBIO
3	$2,419,908,598,386,268	$2,419,464,006,269,573.00	$13,721	$499.76	+$2419908598.37M → NBIO
4	$13,171,697,643,084,456,000	$13,169,108,340,884,183,000.00	$15,227	$544.58	+$13171697643084.44M → NBIO
5	$67,004,927,492,790,120,000,000	$66,990,833,776,312,020,000,000.00	$16,885	$593.02	+$67004927492790120.00M → NBIO
6	$318,562,277,003,514,840,000,000,000	$318,490,581,731,097,560,000,000,000.00	$18,713	$645.34	+$318562277003514871808.00M → NBIO
7	$1,415,484,168,853,553,000,000,000,000,000	$1,415,143,307,217,159,200,000,000,000,000.00	$20,724	$701.81	+$1.415484168853553e+24M → NBIO
8	$5,878,130,573,362,507,000,000,000,000,000,000	$5,876,616,005,301,833,000,000,000,000,000,000.00	$22,938	$762.73	+$5.878130573362507e+27M → NBIO
9	$22,813,793,009,840,743,000,000,000,000,000,000,000	$22,807,503,410,127,248,000,000,000,000,000,000,000.00	$25,372	$828.41	+$2.2813793009840744e+31M → NBIO
10	$82,752,356,187,738,840,000,000,000,000,000,000,000,000	$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00	$28,047	$899.19	+$8.275235618773884e+34M → NBIO

NBIO vs RYLD: Complete Analysis 2026

NBIO — Stock

Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. In addition, the company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. Nascent Biotech, Inc. is based in Vero Beach, Florida.

Full NBIO Calculator →

RYLD — ETF

RYLD is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in RYLD shares.

Full RYLD Calculator →

📬

Get this NBIO vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NBIO vs SCHD NBIO vs JEPI NBIO vs O NBIO vs KO NBIO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.